Agenus to host october stakeholder briefing showcasing bot/bal global momentum and post-esmo insights

Lexington, mass.--(business wire)---- $agen #esmo2025--agenus inc. (“agenus”) (nasdaq: agen), a leader in immuno-oncology, will host a virtual stakeholder briefing on tuesday, october 21, 2025, at 4:00 p.m. et. the webcast will feature updates from leading experts on recent clinical progress and expanding international access for its immunotherapy combination botensilimab (bot) and balstilimab (bal). the session will be moderated by garo armen, phd, founder, chairman, and ceo, and conclude with a live q&a. fea.
AGEN Ratings Summary
AGEN Quant Ranking